Φορτώνει......
Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment trial
INTRODUCTION: The Strategic Timing of AntiRetroviral Treatment (START) trial has recruited antiretroviral-naïve individuals with high CD4 cell counts from all world regions. We describe the distribution of cardiovascular (CVD) risk factors, overall and by geographic region, at study baseline. METHOD...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | HIV Med |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4341949/ https://ncbi.nlm.nih.gov/pubmed/25711323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hiv.12233 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|